Prostate cancer and Hedgehog signalling pathway
Autor: | J. Cassinello Espinosa, G. Aparicio Gallego, R. García Campelo, S. Díaz Prado, L. M. Antón Aparicio, M. Valladares Ayerbes, M. Reboredo López |
---|---|
Rok vydání: | 2007 |
Předmět: |
Male
Cancer Research Pathology medicine.medical_specialty Cell Morphogenesis Biology medicine.disease_cause Models Biological Mesoderm Prostate development medicine Animals Humans Hedgehog Proteins Progenitor cell Autocrine signalling Hedgehog Prostate cancer Cell growth Prostate Prostatic Neoplasms Epithelial Cells General Medicine Hh signalling Cell biology medicine.anatomical_structure Oncology Tumorigenesis Stem cell Carcinogenesis Signal Transduction |
Zdroj: | ResearcherID RUC. Repositorio da Universidade da Coruña instname |
ISSN: | 1699-3055 1699-048X |
DOI: | 10.1007/s12094-007-0080-x |
Popis: | [Abstract] The Hedgehog (Hh) family of intercellular signalling proteins have come to be recognised as key mediators in many fundamental processes in embryonic development. Their activities are central to the growth, patterning and morphogenesis of many different regions within the bodies of vertebrates. In some contexts, Hh signals act as morphogens in the dose-dependent induction of distinct cell fates within a target field, in others as mitogens in the regulation of cell proliferation or as inducing factors controlling the form of a developing organ. These diverse functions of Hh proteins raise many intriguing questions about their mode of action. Various studies have now demonstrated the function of Hh signalling in the control of cell proliferation, especially for stem cells and stem-like progenitors. Abnormal activation of the Hh pathway has been demonstrated in a variety of human tumours. Hh pathway activity in these tumours is required for cancer cell proliferation and tumour growth. Recent studies have uncovered the role for Hh signalling in advanced prostate cancer and demonstrated that autocrine signalling by tumour cells is required for proliferation, viability and invasive behaviour. Thus, Hh signalling represents a novel pathway in prostate cancer that offers opportunities for prognostic biomarker development, drug targeting and therapeutic response monitoring. |
Databáze: | OpenAIRE |
Externí odkaz: |